Tired of paying for Adobe Illustrator's monthly subscription fees? Here are eight alternatives for anyone who needs vector ...

Most mainstream apps available for Macs are also available for Windows PCs. However, you won't see all macOS apps on Windows ...

Adobe Substance 3D Designer is now up to version 14 and is stronger than ever. Recent years have seen an explosion in its ...

I got to play around with the latest versions of Adobe Creative Cloud. I was surprised to find the most useful tools in this ...

Australian researchers are about to launch a human trial to treat spinal cord injury by transplanting cells from the noses of paralysed patients into the damaged area. Griffith University ...

After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment Vandana Singh Fri, Oct 18, 2024, 2:34 PM 2 min read ...

The drug failed to improve survival for patients with advanced bladder cancer in the trial. There were also a higher number of deaths, opens new tab, associated with complications related to ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for bladder cancer in 2021, failed its confirmatory trial earlier this year. Gilead ...

But many popular features like Photoshop’s Remove tool and Adobe’s Fresco painting app made their first appearance as “sneaks,” so there’s a good chance we may see these in Illustrator ...

Four exceptions, a distinct group among the multitude of men on trial for rape before the Vaucluse ... the publisher may only be liable for the French version. Parce qu’une autre personne ...

Adobe has announced a host of new features for Photoshop and Illustrator at its Adobe Max 2024 event. The new features aim to enhance speed, precision and productivity across creative workflows.